Maurizio Rocchetti

Predictive Pharmacokinetic-Pharmacodynamic Modeling of Tumor Growth Kinetics in Xenograft Models after Administration of Anticancer Agents

Monica Simeoni, Paolo Magni, Cristiano Cammia et al. · Cancer Research · 2004 · 499 citations · Full text

Medicine, Oncology, Pharmacology +16

PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer

Patrizia Carpinelli, Roberta Ceruti, Maria Laura Giorgini et al. · Molecular Cancer Therapeutics · 2007 · 244 citations

Medicine, Oncology, Pharmacology +16

Histological effects of givinostat in boys with Duchenne muscular dystrophy

P. Bettica, Stefania Petrini, Valentina Doria et al. · Neuromuscular Disorders · 2016 · 207 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +17

1,4,5,6-Tetrahydropyrrolo[3,4-<i>c</i>]pyrazoles:  Identification of a Potent Aurora Kinase Inhibitor with a Favorable Antitumor Kinase Inhibition Profile

Daniele Fancelli, Jürgen Moll, Mario Varasi et al. · Journal of Medicinal Chemistry · 2006 · 190 citations · Full text

Medicine, Medicinal Chemistry, Oncology +13

Preclinical Studies in the mdx Mouse Model of Duchenne Muscular Dystrophy with the Histone Deacetylase Inhibitor Givinostat

Silvia Consalvi, Chiara Mozzetta, P. Bettica et al. · Molecular Medicine · 2013 · 165 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17